D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 43 Citations 6,012 124 World Ranking 14573 National Ranking 146

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • DNA

Immunology, Molecular biology, Hepatitis C virus, Virus and Cell biology are his primary areas of study. His Immunology research is multidisciplinary, incorporating perspectives in Apoptosis and Cancer research. His Molecular biology research is multidisciplinary, relying on both Phosphoprotein, Gene, Transfection, Small nuclear RNA and Splenocyte.

His Virus research is within the category of Virology. His Virology research includes themes of Plasmid, DNA vaccination, Antibody and Heterologous. His biological study spans a wide range of topics, including Cell cycle checkpoint, Cytotoxic T cell, In vitro, Cytokine and In vivo.

His most cited work include:

  • Local structural elements in the mostly unstructured transcriptional activation domain of human p53. (265 citations)
  • STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice (259 citations)
  • Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability (149 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Virology, Immune system, Molecular biology and DNA vaccination. His work is dedicated to discovering how Immunology, Cytotoxic T cell are connected with Cell biology and other disciplines. His work carried out in the field of Virology brings together such families of science as Plasmid, Antibody and Recombinant DNA.

In his study, Mesenchymal stem cell, Cancer immunotherapy and Pathology is strongly linked to Cancer research, which falls under the umbrella field of Immune system. His Molecular biology study combines topics from a wide range of disciplines, such as Long terminal repeat and Fusion protein. His research integrates issues of CD8 and Cytokine in his study of T cell.

He most often published in these fields:

  • Immunology (32.29%)
  • Virology (31.77%)
  • Immune system (25.00%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (7.29%)
  • Immune system (25.00%)
  • Cancer research (13.02%)

In recent papers he was focusing on the following fields of study:

Young Chul Sung mainly investigates Internal medicine, Immune system, Cancer research, Cell biology and Pharmacology. His research combines Myeloid and Immune system. The concepts of his Cancer research study are interwoven with issues in Mesenchymal stem cell, Combination therapy, Bone morphogenetic protein 2 and Cancer immunotherapy.

The study incorporates disciplines such as B cell and Genetically modified organism in addition to Cell biology. His study in Pharmacology is interdisciplinary in nature, drawing from both Antibody and Anemia. His CD8 study combines topics in areas such as Vaccination, Virology, Immunization, DNA vaccination and Viral load.

Between 2017 and 2021, his most popular works were:

  • A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3 (14 citations)
  • Bone marrow CX3CR1+ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in mice. (8 citations)
  • Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial. (7 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • DNA

The scientist’s investigation covers issues in Internal medicine, Immune system, Cancer research, Cancer immunotherapy and Granzyme B. All of his Immune system and Immunization and DNA vaccination investigations are sub-components of the entire Immune system study. His Cancer research study integrates concerns from other disciplines, such as Cell culture, Leukocyte proliferation, Natural killer cell, Cytotoxic T cell and Flow cytometry.

His Cancer immunotherapy research includes elements of Immune checkpoint, Innate immune system and Tumor microenvironment. Young Chul Sung combines subjects such as Pharmacokinetics, Pharmacodynamics, Immunogenicity and Immunoglobulin D with his study of Adverse effect. His work deals with themes such as Ex vivo, ELISPOT, Cervical intraepithelial neoplasia and Randomization, which intersect with Clinical endpoint.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice

Mi La Cho;Jung Won Kang;Young Mee Moon;Hyo Jung Nam.
Journal of Immunology (2006)

361 Citations

Local structural elements in the mostly unstructured transcriptional activation domain of human p53.

Hyun Lee;K. Hun Mok;Ranjith Muhandiram;Kyu Hwan Park.
Journal of Biological Chemistry (2000)

341 Citations

Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability

Hyun Jin Shin;Kwan Hyuck Baek;Ae Hwa Jeon;Moon Taek Park.
Cancer Cell (2003)

225 Citations

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients

Tae Jin Kim;Hyun-Tak Jin;Soo-Young Hur;Hyun Gul Yang.
Nature Communications (2014)

220 Citations

A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow.

S S Choi;I C Park;J W Yun;Y C Sung.
Oncogene (1995)

213 Citations

2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity.

Sun-Shin Cha;Min-Sung Kim;Yo Han Choi;Byung-Je Sung.
Immunity (1999)

200 Citations

Hepatitis C Virus Core from Two Different Genotypes Has an Oncogenic Potential but Is Not Sufficient for Transforming Primary Rat Embryo Fibroblasts in Cooperation with the H-ras Oncogene

Jun Chang;Se-Hwan Yang;Young-Gyu Cho;Soon Bong Hwang.
Journal of Virology (1998)

197 Citations

Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.

Chung Heon Ryu;Sang-Hoon Park;Soon A Park;Seong Muk Kim.
Human Gene Therapy (2011)

170 Citations

Transactivation Ability of p53 Transcriptional Activation Domain Is Directly Related to the Binding Affinity to TATA-binding Protein

Jun Chang;Do-Hyung Kim;Seung Woo Lee;Kwan Yong Choi.
Journal of Biological Chemistry (1995)

166 Citations

Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway.

Yunji Park;Seung Woo Lee;Young Chul Sung.
Journal of Immunology (2002)

155 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Young Chul Sung

Vladimir N. Uversky

Vladimir N. Uversky

University of South Florida

Publications: 64

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 26

David B. Weiner

David B. Weiner

The Wistar Institute

Publications: 23

A. Keith Dunker

A. Keith Dunker

Indiana University

Publications: 21

Michael M. C. Lai

Michael M. C. Lai

Academia Sinica

Publications: 19

Chandra S. Verma

Chandra S. Verma

Agency for Science, Technology and Research

Publications: 18

David J. Ecker

David J. Ecker

Ionis Pharmaceuticals (United States)

Publications: 16

Yoon-Seok Chang

Yoon-Seok Chang

Seoul National University Bundang Hospital

Publications: 15

Peter Tompa

Peter Tompa

Vrije Universiteit Brussel

Publications: 14

Sang Heon Cho

Sang Heon Cho

Seoul National University

Publications: 13

Christopher J. Oldfield

Christopher J. Oldfield

Virginia Commonwealth University

Publications: 13

Klaus Überla

Klaus Überla

University of Erlangen-Nuremberg

Publications: 13

Rangarajan Sampath

Rangarajan Sampath

Ionis Pharmaceuticals (United States)

Publications: 13

Ranjit Ray

Ranjit Ray

Saint Louis University

Publications: 12

Chien-Fu Hung

Chien-Fu Hung

Johns Hopkins University

Publications: 11

Ratna B. Ray

Ratna B. Ray

Saint Louis University

Publications: 11

Trending Scientists

Moritz Hardt

Moritz Hardt

University of California, Berkeley

Rolf Jakoby

Rolf Jakoby

TU Darmstadt

Wan Ramli Wan Daud

Wan Ramli Wan Daud

National University of Malaysia

Victor Rico-Gray

Victor Rico-Gray

Universidad Veracruzana

Nico Stuurman

Nico Stuurman

University of California, San Francisco

Koen Hufkens

Koen Hufkens

Ghent University

John D. Lenters

John D. Lenters

University of Wisconsin–Madison

G. Allen Burton

G. Allen Burton

University of Michigan–Ann Arbor

Eng Eong Ooi

Eng Eong Ooi

National University of Singapore

Saija Mauno

Saija Mauno

University of Jyväskylä

Mark A. Whisman

Mark A. Whisman

University of Colorado Boulder

Marja A. Boermeester

Marja A. Boermeester

University of Amsterdam

Catey Bunce

Catey Bunce

King's College London

Honglei Chen

Honglei Chen

Michigan State University

Stephen S. Cha

Stephen S. Cha

Mayo Clinic

Vikas Gupta

Vikas Gupta

Princess Margaret Cancer Centre

Something went wrong. Please try again later.